Oncological Results of Neoadjuvant Chemohormonal Therapy in Patients With High and Very High-Risk Prostate Cancer

Onkourologiya - Russian Federation
doi 10.17650/1726-9776-2020-16-1-54-63
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House ABV Press

Related search

Review of the Article “Oncological Results of Neoadjuvant Chemohormonal Therapy in Patients With High and Very High-Risk Prostate Cancer”

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2020English

Neoadjuvant and Adjuvant Chemohormonal Therapy in Patients With High-Risk and Very High-Risk Prostate Cancer: Our Experience

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2018English

Possible Risk Factors Associated With Relapse in Patients Treated With Neoadjuvant Chemohormonal Therapy for High Risk Prostate Cancer

The Open Prostate Cancer Journal
2011English

Feasibility of Neoadjuvant Ad-Reic Gene Therapy in Patients With High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2015English

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients With High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy

PLoS ONE
Multidisciplinary
2016English

Comparative Analysis of Long-Term Results of High-Tech External Beam Therapy and Combined Radiotherapy in Patients With Prostate Cancer and High Risk of Progression

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Mp69-12 Predictors of Surgical Cure in Men With Very High Risk Prostate Cancer

Journal of Urology
Urology
2016English

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy